Search results
2 Top Stocks to Buy Now for Years of Passive Income
Motley Fool via Yahoo Finance· 3 hours agoGiven its share price, Johnson & Johnson's dividend yields around 3.4%. That's more than double the yield of the average stock (approximately 1.4%)...
3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold
Motley Fool via Yahoo Finance· 1 hour agoShareholders can look forward to more significant payout bumps. Last year, Johnson & Johnson...
Is There a New COVID Booster to Prevent Against FLiRT Variants?
Good Housekeeping via AOL· 2 weeks agoCOVID-19 vaccines to make them more effective against the currently-circulating strains of COVID-19
Vaccine critics misrepresent US appeals court ruling over Covid-19 shots
AFP via Yahoo News· 2 weeks agoVaccine skeptics are claiming a US federal appeals court ruled in June 2024 that Covid-19 shots are...
Moderna's COVID-Flu Vaccine Shows Stronger Immune Response Than Individual Shots, Late-Stage Trial...
Forbes· 2 weeks agoModerna on Monday said its combination COVID-19 and flu shot elicits a stronger immune response...
Upstate NY midwife pleads guilty to giving COVID-19 vaccine cards to the unvaccinated
New York Daily News· 4 days agoA midwife who helped an upstate clinic hand out thousands of COVID vaccine cards to people who never...
Moderna’s COVID, flu combination vaccine shows stronger immune response, company announces
WHIO-TV 7 Dayton· 2 weeks agoModerna is working on a single vaccine that it says will protect people against both COVID-19 and...
Maker of COVID vaccines and naloxone exits Baltimore with sale of plant
The Baltimore Banner· 2 days agoGaithersburg-based Emergent BioSolutions is officially leaving Baltimore after a tumultuous stretch...
Novavax’s South African Phase IIb COVID-19 vaccine trial likely to reveal results within next...
Pharmaceutical Technology via Yahoo Finance· 4 days agoSouth Africa’s existing regulatory, consent and ethics frameworks around HIV vaccine trial investigations helped with regards to quick initiation and straightforward progress ...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 23 hours agoConclusion While other large drugmakers face continued challenges, Lilly has stayed strong. Pfizer...